These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains. Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759 [TBL] [Abstract][Full Text] [Related]
26. LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents. Haisma EM; de Breij A; Chan H; van Dissel JT; Drijfhout JW; Hiemstra PS; El Ghalbzouri A; Nibbering PH Antimicrob Agents Chemother; 2014 Aug; 58(8):4411-9. PubMed ID: 24841266 [TBL] [Abstract][Full Text] [Related]
27. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran. Ghahremani M; Jazani NH; Sharifi Y J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049 [TBL] [Abstract][Full Text] [Related]
28. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms. Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828 [TBL] [Abstract][Full Text] [Related]
29. CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA. Xie J; Li Y; Guo X; Rao J; Yan T; Mou L; Wu X; Xie X; Yang W; Zhang B Biochimie; 2020 Sep; 176():1-11. PubMed ID: 32590058 [TBL] [Abstract][Full Text] [Related]
30. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria. Luther MK; Mermel LA; LaPlante KL Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824 [TBL] [Abstract][Full Text] [Related]
31. In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods. Baldoni D; Steinhuber A; Zimmerli W; Trampuz A Antimicrob Agents Chemother; 2010 Jan; 54(1):157-63. PubMed ID: 19805560 [TBL] [Abstract][Full Text] [Related]
32. Antimicrobial activity of a natural compound and analogs against multi-drug-resistant Gram-positive pathogens. Shah KN; Shah PN; Agobe FO; Lovato K; Gao H; Ogun O; Hoffman C; Yabe-Gill M; Chen Q; Sweatt J; Chirra B; Muñoz-Medina R; Farmer DE; Kürti L; Cannon CL Microbiol Spectr; 2024 Mar; 12(3):e0151522. PubMed ID: 38289721 [TBL] [Abstract][Full Text] [Related]
33. Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci. Sandiford S; Upton M Antimicrob Agents Chemother; 2012 Mar; 56(3):1539-47. PubMed ID: 22155816 [TBL] [Abstract][Full Text] [Related]
34. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium. Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms of Linezolid Resistance Among Clinical Ruiz-Ripa L; Feßler AT; Hanke D; Eichhorn I; Azcona-Gutiérrez JM; Alonso CA; Pérez-Moreno MO; Aspiroz C; Bellés A; Schwarz S; Torres C Microb Drug Resist; 2021 Feb; 27(2):145-153. PubMed ID: 32456543 [TBL] [Abstract][Full Text] [Related]
36. Delpech G; Ceci M; Lissarrague S; García Allende L; Baldaccini B; Sparo M Biofouling; 2020 Mar; 36(3):266-275. PubMed ID: 32338055 [No Abstract] [Full Text] [Related]
37. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections. Desbois AP; Gemmell CG; Coote PJ Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480 [TBL] [Abstract][Full Text] [Related]
38. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital. Hashem AA; Abd El Fadeal NM; Shehata AS J Med Microbiol; 2017 Jun; 66(6):744-752. PubMed ID: 28598310 [TBL] [Abstract][Full Text] [Related]
39. Serum Stable and Low Hemolytic Temporin-SHa Peptide Analogs Disrupt Cell Membrane of Methicillin-Resistant Staphylococcus aureus (MRSA). Maharjan R; Khan AI; Nadeem-Ul-Haque M; Maresca M; Choudhary MI; Shaheen F; Simjee SU Probiotics Antimicrob Proteins; 2022 Apr; 14(2):391-405. PubMed ID: 35092568 [TBL] [Abstract][Full Text] [Related]
40. Deciphering Structure-Function Relationship Unveils Salt-Resistant Mode of Action of a Potent MRSA-Inhibiting Antimicrobial Peptide, RR14. Kao CC; Lin TL; Lin CJ; Tseng TS J Bacteriol; 2022 Dec; 204(12):e0031222. PubMed ID: 36377870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]